Robert Orlowski
M.D. Anderson Cancer Center
4
4
3
N/A
0
10
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Shaji Kumar
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Brenda Sandmaier
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Shaji Kumar, M.D.
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Sikander Ailawadhi, M.D.
Mayo Clinic
Shared therapeutic areas:
Brenda Sandmaier
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Luhua (Michael) Wang
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Leona Holmberg
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Ryotaro Nakamura
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Bilal Omer, MD
Baylor College of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Noopur Raje, MD
Massachusetts General Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma
Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
All 4 trials loaded